product monograph
... No studies evaluating sexual function or reproduction in humans were conducted with NEULASTA. Glomerulonephritis Glomerulonephritis has been reported in patients receiving filgrastim and pegfilgrastim. Generally, events of glomerulonephritis resolved after dose reduction or withdrawal of filgrastim ...
... No studies evaluating sexual function or reproduction in humans were conducted with NEULASTA. Glomerulonephritis Glomerulonephritis has been reported in patients receiving filgrastim and pegfilgrastim. Generally, events of glomerulonephritis resolved after dose reduction or withdrawal of filgrastim ...
C) Familial Hypercholesterolaemia
... Statins come in tablet form and work by slowing down the production of cholesterol in the liver, which is where most of the body’s cholesterol is made. Statins are thoroughly tested and very effective at lowering cholesterol, LDL in particular. They are generally well tolerated, and reassuringly hav ...
... Statins come in tablet form and work by slowing down the production of cholesterol in the liver, which is where most of the body’s cholesterol is made. Statins are thoroughly tested and very effective at lowering cholesterol, LDL in particular. They are generally well tolerated, and reassuringly hav ...
Antiproteinuric effect of add-on paricalcitol in
... compared by paired or unpaired Student t-test and McNemar or chi-square test for categorical variables. ANOVA for repeated measures with Bonferroni as post hoc test are also used where appropriate. A two-tailed P-value of <0.05 is considered significant. Data are analysed using SPSS 20.0 (SPSS, Inc., ...
... compared by paired or unpaired Student t-test and McNemar or chi-square test for categorical variables. ANOVA for repeated measures with Bonferroni as post hoc test are also used where appropriate. A two-tailed P-value of <0.05 is considered significant. Data are analysed using SPSS 20.0 (SPSS, Inc., ...
Cannabis sativa - Bakersfield College
... Drug Addiction and the Brain’s Reward Circuits Chemicals That Harm with Pleasure ...
... Drug Addiction and the Brain’s Reward Circuits Chemicals That Harm with Pleasure ...
Perioperative anesthesia clinical considerations of
... and Ayurveda, a science of herbs unique to the Indian sub-continent for over 5000 years. Naturopathic medicine Naturopathic medicine is an alternative medical system in which practitioners work with ‘‘natural healing forces’’ within the body, with a goal of helping the body heal from disease and att ...
... and Ayurveda, a science of herbs unique to the Indian sub-continent for over 5000 years. Naturopathic medicine Naturopathic medicine is an alternative medical system in which practitioners work with ‘‘natural healing forces’’ within the body, with a goal of helping the body heal from disease and att ...
of patients
... Allopurinol is an appropriate long-term urate lowering drug; it should be started at a low dose (for example 100mg daily), and increased by 100mg every 2-4 weeks if required; the dose should be adjusted in patients with renal impairment; if allopurinol toxicity occurs, options include other xanthine ...
... Allopurinol is an appropriate long-term urate lowering drug; it should be started at a low dose (for example 100mg daily), and increased by 100mg every 2-4 weeks if required; the dose should be adjusted in patients with renal impairment; if allopurinol toxicity occurs, options include other xanthine ...
Updating the Beers Criteria for Potentially Inappropriate Medication
... lems in elderly patients, including the use of lists containing specific drugs to avoid in the elderly and appropriateness indexes applied by pharmacists or clinicians.1,10,11 Systematic review of the evidence-based literature on medication use in elderly patients is another approach to defining th ...
... lems in elderly patients, including the use of lists containing specific drugs to avoid in the elderly and appropriateness indexes applied by pharmacists or clinicians.1,10,11 Systematic review of the evidence-based literature on medication use in elderly patients is another approach to defining th ...
CV Strategy Research
... AZ was ranked highest because of their diverse products, their research activity and support of CME Sanofi was second because of their products and the level of support (education, information, materials) they provide Pfizer was third because of their products and their support of CME AZ was r ...
... AZ was ranked highest because of their diverse products, their research activity and support of CME Sanofi was second because of their products and the level of support (education, information, materials) they provide Pfizer was third because of their products and their support of CME AZ was r ...
12
... of naturally occurring bioactive substances and the design and synthesis of new molecules with biological activity. Many compounds have been identified by these means, but the lack of selectivity of the majority of current highly toxic drugs used for chemotherapy has motivated the search for other m ...
... of naturally occurring bioactive substances and the design and synthesis of new molecules with biological activity. Many compounds have been identified by these means, but the lack of selectivity of the majority of current highly toxic drugs used for chemotherapy has motivated the search for other m ...
Compliance with the Adult Treatment Panel III guidelines for
... fat ,7% of calories, cholesterol ,200 mg/day, increased soluble fiber [10225 g/day] and plant sterols/stanols [2 g/ day]), weight management and increased physical activity. The drug therapy was as per the ATP III guidelines.3 The initial drug of choice is a statin/bile acid sequestrant/nicotinic ac ...
... fat ,7% of calories, cholesterol ,200 mg/day, increased soluble fiber [10225 g/day] and plant sterols/stanols [2 g/ day]), weight management and increased physical activity. The drug therapy was as per the ATP III guidelines.3 The initial drug of choice is a statin/bile acid sequestrant/nicotinic ac ...
PART III: CONSUMER INFORMATION Pr ADALAT® XL
... result in a large immediate release of the drug. You can take this medication with or without food. Your doctor will tell you how much of this medicine to use and how often. Your dose may need to be changed several times in order to find out what works best for you. Follow your doctor's treatment pl ...
... result in a large immediate release of the drug. You can take this medication with or without food. Your doctor will tell you how much of this medicine to use and how often. Your dose may need to be changed several times in order to find out what works best for you. Follow your doctor's treatment pl ...
The impact of pharmacogenetics on the development and use of
... substantially less than 100, and 2 had fewer than 50 subjects, suggesting they were inadequately powered to identify reliably anything other than the strongest of genetic associations. Confounds relating to variability in ethnicity, sample selection, prior treatment, symptom severity and many other ...
... substantially less than 100, and 2 had fewer than 50 subjects, suggesting they were inadequately powered to identify reliably anything other than the strongest of genetic associations. Confounds relating to variability in ethnicity, sample selection, prior treatment, symptom severity and many other ...
osphena
... • Osphena is an estrogen agonist/antagonist indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause • Osphena selectively binds to estrogen receptors, inducing changes to the vaginal epithelium and decreasing vaginal pH • There is an i ...
... • Osphena is an estrogen agonist/antagonist indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause • Osphena selectively binds to estrogen receptors, inducing changes to the vaginal epithelium and decreasing vaginal pH • There is an i ...
Is there still a place for metoclopramide as a prokinetic drug in
... 4. Nguyen NQ, Chapman MJ, Fraser RJ, Bryant LK, Holloway RH: Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Crit Care Med 2007, 35:483–489. 5. Ritz MA, Chapman MJ, Fraser RJ, Finnis ME, Butler RN, Cmielewski P, Davidson GP, Rea D: Erythro ...
... 4. Nguyen NQ, Chapman MJ, Fraser RJ, Bryant LK, Holloway RH: Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Crit Care Med 2007, 35:483–489. 5. Ritz MA, Chapman MJ, Fraser RJ, Finnis ME, Butler RN, Cmielewski P, Davidson GP, Rea D: Erythro ...
youngs 3-25 - Iowa State University
... AMDUCA (animal medicinal drug use clarification act of 1994 [as amended]) defined: ...
... AMDUCA (animal medicinal drug use clarification act of 1994 [as amended]) defined: ...
cannabinoids: cesamet®, marinol®, and sativex
... relaxation, euphoria, reduction in intraocular pressure, reflux, fatigue, tachycardia, anxiety, and disorientation. Although cannabinoid products may be prescribed to treat pain, concerns exist in the medical literature regarding their long-term use and potential for serious adverse effects and drug ...
... relaxation, euphoria, reduction in intraocular pressure, reflux, fatigue, tachycardia, anxiety, and disorientation. Although cannabinoid products may be prescribed to treat pain, concerns exist in the medical literature regarding their long-term use and potential for serious adverse effects and drug ...
Tussionex®
... Pediatric Use: In pediatric patients, as well as adults, the respiratory center is sensitive to the depressant action of narcotic cough suppressants in a dose-dependent manner. Benefit to risk ratio should be carefully considered especially in pediatric patients with respiratory embarrassment (e.g., ...
... Pediatric Use: In pediatric patients, as well as adults, the respiratory center is sensitive to the depressant action of narcotic cough suppressants in a dose-dependent manner. Benefit to risk ratio should be carefully considered especially in pediatric patients with respiratory embarrassment (e.g., ...
Gemzar - Eli Lilly and Company
... distress syndrome (ARDS), has been reported. In some cases, these pulmonary events can lead to fatal respiratory failure despite discontinuation of therapy. The onset of pulmonary symptoms may occur up to 2 weeks after the last dose of Gemzar. Discontinue Gemzar in patients who develop unexplained d ...
... distress syndrome (ARDS), has been reported. In some cases, these pulmonary events can lead to fatal respiratory failure despite discontinuation of therapy. The onset of pulmonary symptoms may occur up to 2 weeks after the last dose of Gemzar. Discontinue Gemzar in patients who develop unexplained d ...
PDF - The Dermatologist
... Skincare companies also can do other events for your office. For instance, one company provided the use of an UV camera system in our medispa so that everyone who came to my office for a 3-day period of time had UV pictures made of their skin. Then, we, along with the company representative who rema ...
... Skincare companies also can do other events for your office. For instance, one company provided the use of an UV camera system in our medispa so that everyone who came to my office for a 3-day period of time had UV pictures made of their skin. Then, we, along with the company representative who rema ...
System suitability test
... Indirect separation is based on the use of chiral derivatization reagents to form diastereomeric derivatives which differ in their chemical and physical behavior and therefore can be separated on achiral stationary phases. This approach circumvents the need for expensive columns with chiral statio ...
... Indirect separation is based on the use of chiral derivatization reagents to form diastereomeric derivatives which differ in their chemical and physical behavior and therefore can be separated on achiral stationary phases. This approach circumvents the need for expensive columns with chiral statio ...
INSIGHT: Alcohol and Other Drug
... Alcohol and other legal drugs are produced and packaged in quality controlled environments. That is, they are produced in sterile conditions and the exact amount of the drug is known. Counter to this, illegal drugs are produced in environments that may not be clean and sanitary. They are sold in unc ...
... Alcohol and other legal drugs are produced and packaged in quality controlled environments. That is, they are produced in sterile conditions and the exact amount of the drug is known. Counter to this, illegal drugs are produced in environments that may not be clean and sanitary. They are sold in unc ...
Bad Pharma
.JPG?width=300)
Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products. The book was published in September 2012 in the UK by the Fourth Estate imprint of HarperCollins, and in February 2013 in the United States by Faber and Faber.Goldacre argues in the book that ""the whole edifice of medicine is broken"" because the evidence on which it is based is systematically distorted by the pharmaceutical industry. He writes that the industry finances most of the clinical trials into its own products and much of doctors' continuing education, that clinical trials are often conducted on small groups of unrepresentative subjects and negative data is routinely withheld, and that apparently independent academic papers may be planned and even ghostwritten by pharmaceutical companies or their contractors, without disclosure. Goldacre calls the situation a ""murderous disaster,"" and makes suggestions for action by patients' groups, physicians, academics and the industry itself.Responding to the book's publication, the Association of the British Pharmaceutical Industry issued a statement arguing that the examples the book offers are historical, that the concerns have been addressed, that the industry is among the most regulated in the world, and that it discloses all data in accordance with international standards.In January 2013 Goldacre joined the Cochrane Collaboration, British Medical Journal and others in setting up AllTrials, a campaign calling for the results of all past and current clinical trials to be reported. The British House of Commons Public Accounts Committee expressed concern in January 2014 that drug companies were still only publishing around 50 percent of clinical-trial results.